American Oriental Bioengineering Current Cash

American Oriental Bioengineering (AOBI) currently reports a current cash of $3.2M as of September 2013. That compares with $26M in the prior-year period — down 87.8% year over year. Use the charts on this page to explore American Oriental Bioengineering's current cash history and peer comparisons.

American Oriental Bioengineering's current cash decreased from $26M to $3.2M — a 87.8% year-over-year decrease (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

American Oriental Bioengineering reported $3.2M in current cash as of September 2013. That compares with $26M in the prior-year period — down 87.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for American Oriental Bioengineering, and consider following AOBI for alerts when major investors trade the stock.

American Oriental Bioengineering is classified in the Healthcare sector. On current cash, it currently shows $3.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AOBI with unrelated industries.